Article
Bromodomain Protein BRD4-Mediated Mutant p53 Transcription Promotes TNBC Progression
2 Dec 2022
Abstract excerpt
is the most common mutated gene in human cancer. Mutant p53 protein loses its tumor-suppressor properties and gains oncogenic activity. Mutant p53 is a therapeutic target in a broad range of cancer types. However, how mutant p53 is epigenetically regulated during tumor progression remains elusive. In this study, we found that the upregulation of mutant p53 is mediated by bromodomain protein BRD4 in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
